BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Centuori SM, Bauman JE. c-Met Signaling as a Therapeutic Target in Head and Neck Cancer. Cancer J 2022;28:346-53. [PMID: 36165722 DOI: 10.1097/PPO.0000000000000619] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Palumbo C, Benvenuto M, Focaccetti C, Albonici L, Cifaldi L, Rufini A, Nardozi D, Angiolini V, Bei A, Masuelli L, Bei R. Recent findings on the impact of ErbB receptors status on prognosis and therapy of head and neck squamous cell carcinoma. Front Med (Lausanne) 2023;10:1066021. [PMID: 36817764 DOI: 10.3389/fmed.2023.1066021] [Reference Citation Analysis]
2 Katase N, Nishimatsu S, Yamauchi A, Okano S, Fujita S. Establishment of anti-DKK3 peptide for the cancer control in head and neck squamous cell carcinoma (HNSCC). Cancer Cell Int 2022;22:352. [DOI: 10.1186/s12935-022-02783-9] [Reference Citation Analysis]